| [1] |
Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei.
Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504.
|
| [2] |
Zhang Peize, Gao Qian, Deng Guofang.
[18F]FDT-PET-CT technology that may bring revolutionary changes to tuberculosis clinical research
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 262-265.
|
| [3] |
Huang Misun, Wu Yaning, Li Guilian, Liu Haican.
Research advances of Mycobacterium tuberculosis enrichment technology
[J]. Chinese Journal of Antituberculosis, 2025, 47(3): 369-373.
|
| [4] |
You Chengdong, Zhu Ling, Li Peibo.
Research progress on serum trace elements in the development and nutritional support of pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 218-223.
|
| [5] |
Fu Ying, Xiong Yangyang, Fang Si, Li Chuanxiang, Guo Hongrong.
The research progress on the relationship between serum albumin and its derivative biomarkers and chronic obstructive pulmonary disease
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 231-236.
|
| [6] |
Liu Ruihua, Sarina , Wang Furong.
Interaction between lung cancer and tuberculosis in disease development and progression
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 102-111.
|
| [7] |
Sun Danyuchen, Liu Yuhong.
Research progress on active case finding of tuberculosis in the elderly population: a literature review
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 96-101.
|
| [8] |
Li Wenhan, Yang Jing, Li Chunhua.
Research progress of artificial intelligence in pulmonary tuberculosis imaging diagnosis and drug resistance prediction
[J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1098-1103.
|
| [9] |
Wang Yiting, Meng Xiangli, Fu Yin, Cao Xiaolong, Zheng Huiwen, He Wencong, Song Zexuan, Zhao Yanlin.
Advances in the application of metagenomic sequencing for tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 976-981.
|
| [10] |
He Xiangrong, Chen Hua, Chen Pinru, Liang Feng, Ren Huili, Zhu Jialou, Hu Jinxing, Tan Yaoju.
A case report and literature review of Mycobacterium asiaticum pulmonary disease
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 763-769.
|
| [11] |
Xu Wenhui, Zhang Yanqiu, Shi Jie, Sun Dingyong.
Advances in biomarker research for tuberculosis diagnosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 713-721.
|
| [12] |
Zhang Jingyi, Dai Shanshan, Zhang Liliang, Tian Jiashuai, Cai Xinyu, Gao Guangying.
Intrudoction of study on the capitation compensation mechanism among pulmonary tuberculosis patients with a full period of treatment and payment standard
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 502-508.
|
| [13] |
Yang Jing, Xiao Lijuan, Fang Tanwei.
Development strategy and prospect of tuberculosis mRNA vaccines
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 590-595.
|
| [14] |
Shang Xuetian, Pan Liping.
Role of tissue kallikrein family in pathogenesis of microorganism infection
[J]. Chinese Journal of Antituberculosis, 2024, 46(2): 239-244.
|
| [15] |
Chen Yujie, Wang Linghua, Cheng Xiaoyan, Li Huiyuan.
Research progress on latent tuberculosis infection in medical staff
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1541-1547.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
